Sijin Wen

Long-term results of the fludarabine, cyclophosphamide, and rituximab regimen as initial therapy of chronic lymphocytic leukemia

Constantine S. Tam, Susan O’Brien, William G. Wierda et al. · Blood · 2008 · 689 citations · Full text

Medicine, Oncology, Pharmacotherapy +16

Personalized Medicine in a Phase I Clinical Trials Program: The MD Anderson Cancer Center Initiative

Apostolia M. Tsimberidou, Nancy G. Iskander, David S. Hong et al. · Clinical Cancer Research · 2012 · 541 citations · Full text

Medicine, Molecular Medicine, Oncology +17

Chemoimmunotherapy With Fludarabine, Cyclophosphamide, and Rituximab for Relapsed and Refractory Chronic Lymphocytic Leukemia

William G. Wierda, Susan O’Brien, Sijin Wen et al. · Journal of Clinical Oncology · 2005 · 523 citations

Medicine, Oncology, Pharmacotherapy +12

CD8 tumor-infiltrating lymphocytes are predictive of survival in muscle-invasive urothelial carcinoma

Padmanee Sharma, Yu Shen, Sijin Wen et al. · Proceedings of the National Academy of Sciences · 2007 · 517 citations

Life Sciences, Immunology, Oncology +17

Phase II Trial of Infusional Fluorouracil, Irinotecan, and Bevacizumab for Metastatic Colorectal Cancer: Efficacy and Circulating Angiogenic Biomarkers Associated With Therapeutic Resistance

Scott Kopetz, Paulo M. Hoff, Jeffrey S. Morris et al. · Journal of Clinical Oncology · 2009 · 487 citations · Full text

Medicine, Oncology, Pharmacology +17